EUVIMEDEUVIMED entdecken
Crossref

A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis

Zhiwen Chen, Mengyu Jiang, Liang Mo, Chi Zhou, Haoran Huang, Chao Ma, Zhangzheng Wang, Yinuo Fan, Zhenqiu Chen, Bin Fang, Yuhao Liu

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Zhiwen Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China; Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Osteoclasts, Osteoblasts, Estrogens, Bone Resorption. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Guangzhou Municipal Health Commission, Guangdong Provincial Key Laboratory for Translational Cancer Research of Chinese Medicine, Guangzhou University of Chinese Medicine, National Aerospace Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperactive osteoclasts and hypoactive osteoblasts usually result in osteolytic conditions such as estrogen-deficiency bone loss. Few natural compounds that both attenuating bone resorption and enhancing bone formation could exert effects on this imbalance. 5-Deoxycajanin (5-D), an isoflavonoid extracted from Cajan leaf with estrogen-like properties, were found to have beneficial pharmacological effects on rebalancing the activities of osteoclasts and osteoblasts. This study revealed that 5-D at the same concentration could inhibit osteoclastogenesis of BMMs and promoted osteoblast differentiation of BMSCs. 5-D not only attenuated the fluorescent formation of RANKL-induced F-actin belts and NFATc1, but also activated ALP and RUNX2 expressions. As to downstream factor expressions, 5-D could block osteoclast-specific genes and proteins including NFATc1 and CTSK, while increased osteogenic genes and proteins including OPG and OCN, as confirmed by Real-time PCR and Western Blotting. Additionally, the network pharmacology and molecular docking identified the involvement of 5-D in the MIF and MAPK signaling pathways and the stable binding between 5-D and MAPK2K1. Further Western blot studies showed that 5-D decreased the phosphorylation of p38 and ERK in osteoclasts, but promoted these phosphorylations in osteoblasts. In a female C57BL/6J mouse model of estrogen deficiency-induced bone loss, 5-D demonstrated efficacy in enhancing BMD through attenuating osteoclast activities and promoting osteogenesis. These results underscore the potential application of 5-D on treating osteolysis resulting from hyperactive osteoclasts and hypoactive osteoblasts, shedding light on modulating osteoclast-osteoblast homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsOsteoblastsEstrogensBone ResorptionAnimalsMiceFemaleOsteogenesisHomeostasisMice, Inbred C57BLCells, CulturedCell DifferentiationOvariectomyIsoflavonesRANK LigandHumansMolecular Docking SimulationMesenchymal Stem Cells

Stichwörter der Autor:innen

5-DeoxycajaninBone lossOsteoblastsOsteoclasts

Substanzen

EstrogensIsoflavonesRANK Ligand

Autor:innen und Institutionen

  • The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China; Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Guangzhou University of Chinese Medicine, Guangzhou, China.
  • The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China; Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China; Guangzhou University of Chinese Medicine, Guangzhou,…
  • The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China; Yangjiang Hospital of Traditional Chinese Medicine, Yangjiang, China.

Förderung

  • Guangzhou Municipal Health Commission
  • Guangdong Provincial Key Laboratory for Translational Cancer Research of Chinese Medicine, Guangzhou University of Chinese Medicine
  • National Aerospace Science Foundation of China
  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Bureau

Zitieren

APA

Chen, Z., Jiang, M., Mo, L., Zhou, C., Huang, H., Ma, C., Wang, Z., Fan, Y., Chen, Z., Fang, B., & Liu, Y. (2024). A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112906

Vancouver

Chen Z, Jiang M, Mo L, Zhou C, Huang H, Ma C, et al. A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112906

BibTeX
@article{Chen2024,
  author = {Chen, Zhiwen and Jiang, Mengyu and Mo, Liang and Zhou, Chi and Huang, Haoran and Ma, Chao and Wang, Zhangzheng and Fan, Yinuo and Chen, Zhenqiu and Fang, Bin and Liu, Yuhao},
  title = {A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112906}
}
Kostenlos starten →